Self-Directed Upper Extremity Gaming in Inpatients With Stroke

NCT07806097 | Recruiting

• 1 other identifier: STU00224942
• Study Type: interventional
• Target: 30
• Locations: 1 country
• Sites: 1

Brief Summary

STRIVE uses a camera mounted on the in-room TV and a connected laptop to track arm and hand movements during gameplay via markerless motion capture. No controllers or wearable sensors are required, and patients initiate a session with a single button on the TV remote. Games target clinically relevant movements such as reaching and grasping, with difficulty adapting to the user.

Conditions

Stroke

Keywords

gaming; upper extremity; occupational therapy; dosage; reps

Outcome Measures

Primary Outcomes (6)

• Observational Notes

  Taken by study staff during session. Notes are entered into structured template.

  During every session throughout phase 1 (months 3-4) --and during at least 2 sessions for every participant during phase 4 (months 15-18)

• Adherence Notes

  Study staff record days of attempted use and reasons for missed days, when available.

  Throughout all sessions during phase 4 (months 15-18)

• System Usability Scale (SUS)

  10-item assessment, each item rated on a 5-point Likert scale. Items are scored to yield a total score from 0 to 100, with higher scores indicating better perceived usability.

  All sessions of phase 1 (months 3-4) and final sessions of each participant in phase 4 (months 15-18)-- completed at session conclusion following STRIVE engagement.

• Quebec User Evaluation of Satisfaction with Assistive Technology (QUEST)

  Participants are asked to rate their satisfaction for STRIVE on a 5 point scale that ranges from "not satisfied" at all to "very satisfied." Quest has 12 items, with higher scores reflecting higher user satisfaction.

  All sessions of phase 1 (months 3-4) and final sessions of each participant in phase 4 (months 15-18)-- administered at session conclusion following STRIVE engagement.

• STRIVE system logs

  STRIVE will automatically record data that includes session start/end time, duration, active play time, number of sessions completed, and performance metrics.

  Throughout phase 1 (months 3-4) and phase 4 (months 15-18)

• Total time of Engagement for Strive

  STRIVE will automatically record data that includes session start/end time. Duration will be calculated via END\_TIME-START\_TIME.

  Every session during phase 1 (months 3-4) and phase 4 (months 15-18)

Secondary Outcomes (6)

• Rates and incidents

  All sessions of each participant in phase 4 (months 15-18)

• Intrinsic Motivation Inventory (IMI)- short form

  All sessions of phase 1 (months 3-4) and final sessions of each participant in phase 4 (months 15-18)-- administered at session conclusion following STRIVE engagement.

• Pittsburgh Rehabilitation Participation Scale (PRPS)

  All sessions of phase 1 (months 3-4) and at least 2 sessions for each participant in phase 4 (months 15-18)-- administered at session conclusion following STRIVE engagement.

• Number of STRIVE Sessions Completed

  Every session in phase 4 (months 15-18)

• Participant-Rated Acceptability of the STRIVE System

  All sessions of phase 1 (months 3-4) and final sessions of each participant in phase 4 (months 15-18)-- administered at session conclusion following STRIVE engagement.

Other Outcomes (1)

• Participant movement smoothness

  Every session in phase 1 (months 3-4) and phase 4 (months 15-18)

Study Arms (1)

STRIVE participants

EXPERIMENTAL

Participants using STRIVE

Other: Self-Directed Therapeutic Rehab using In-room Virtual Entertainment (STRIVE)

Interventions

Self-Directed Therapeutic Rehab using In-room Virtual Entertainment (STRIVE) OTHER

In-room upper extremity gaming system using markerless motion tracking

STRIVE participants

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• admitted for IP stroke rehabilitation ARAT \>5 and \<40 at enrollment
• sufficient cognition and vision to follow simple instructions
• medically stable for independent seated or supine UE activity

You may not qualify if:

• severe neglect that prevents task engagement
• significant aphasia that prevents understanding of instructions
• medical contraindications to unsupervised UE activity as determined by the treating team

Sponsors & Collaborators

• Milap Sandhu: lead

Study Sites (1)

Shirley Ryan AbilityLab

Chicago, Illinois, 60611-3167, United States

RECRUITING

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular Disorders; Brain Diseases; Central Nervous System Diseases; Nervous System Diseases; Vascular Diseases; Cardiovascular Diseases

Study Officials

• Milap Sandhu

  Shirley Ryan AbilityLab

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Rachel A Kalvakota, OTD, OTR/L

CONTACT

3122383947; rkalvakota@sralab.org

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: SPONSOR INVESTIGATOR
• PI Title: Principal Investigator

Study Record Dates

• First Submitted: July 21, 2026
• First Posted: September 8, 2026
• Study Start: July 20, 2026
• Primary Completion (Estimated): July 20, 2027
• Study Completion (Estimated): December 20, 2027
• Last Updated: September 8, 2026

Record last verified: 2026-09

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)